Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

• Main Author: Lindström, Ulf
• Publication Date: 2021
• Other Authors: Di Giuseppe, Daniela, Delcoigne, Bénédicte, Glintborg, Bente, Möller, Burkhard, Ciurea, Adrian, Pombo-Suarez, Manuel, Sanchez-Piedra, Carlos, Eklund, Kari, Relas, Heikki, Gudbjornsson, Bjorn, Love, Thorvardur Jon, Jones, Gareth T., Codreanu, Catalin, Ionescu, Ruxandra, Nekvindova, Lucie, Závada, Jakub, Atas, Nuh, Yolbas, Servet, Fagerli, Karen Minde, Michelsen, Brigitte, Rotar, Žiga, Tomšič, Matija, Iannone, Florenzo, Santos, Maria, Avila-Ribeiro, Pedro, Ørnbjerg, Lykke Midtbøll, Østergaard, Mikkel, Jacobsson, Lennart T. H., Askling, Johan, Nissen, Michael J.
• Format: Article
• Language: eng
• Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
• Download full: http://hdl.handle.net/10451/48625
• topic: Arthritis; Methotrexate; Psoriatic; Tumour necrosis factor inhibitors

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.